Anti-inflammatory effect of dexmedetomidine combined with hypothermia on acute respiratory distress syndrome in rats

J Surg Res. 2017 Aug:216:179-184. doi: 10.1016/j.jss.2017.05.014. Epub 2017 May 10.

Abstract

Background: To investigate the protective effect of combination of dexmedetomidine and hypothermia on lipopolysaccharide (LPS) induced acute respiratory distress syndrome in rats.

Methods: Fifty male Wistar rats were randomly divided into five groups, with 10 rats in each group. The acute respiratory distress syndrome model was reproduced by LPS injected into the right external jugular vein (L group); only saline was injected into the right external jugular vein for control group (C group). In hypothermia group (T group), the body temperature was lowered to 32.5°C-33.0°C after 1 h of LPS injection, and 10 rats were sacrificed at 8 h. Group dexmedetomidine (D group) and dexmedetomidine combined with hypothermia group (DT group) received intraperitoneal dexmedetomidine 30 min before LPS was injected. The arterial blood gas was determined in all the groups before and 8 h after instillation of saline or LPS, and the oxygenation index (PaO2/FiO2) was calculated. The pro-inflammatory cytokines TNF-alpha (TNF-α) and interleukin- 6 (IL-6) levels were determined by enzyme-linked immunosorbent assay. The expression of inflammatory signaling proteins in bronchial alveolar lavage fluid was determined by Western blot.

Results: Compared with group L, TNF-α and IL-6 levels in serum of rats were significantly lower (P < 0.05), the expression of toll-like receptors 4 and phosphorylated c-Jun N-terminal kinase was significantly lower (P < 0.05), and the p-Akt level was significantly higher (P < 0.05). Moreover, the dexmedetomidine combined with hypothermia treated was superior to the single method.

Conclusions: The combination of dexmedetomidine and hypothermia could alleviate acute lung injury in rats.

Keywords: Acute respiratory distress syndrome; Dexmedetomidine; Hypothermia.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use*
  • Biomarkers / blood
  • Blotting, Western
  • Combined Modality Therapy
  • Dexmedetomidine / therapeutic use*
  • Enzyme-Linked Immunosorbent Assay
  • Hypothermia, Induced*
  • Male
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Respiratory Distress Syndrome / blood
  • Respiratory Distress Syndrome / therapy*
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Biomarkers
  • Dexmedetomidine